BANYAN BIOMARKERS, INC.

Basic Information

12085 RESEARCH DR
ALACHUA, FL, 32615-

Company Profile

n/a

Additional Details

Field Value
DUNS: 168789274
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Clinical utility of serum biomarkers for the management of neonatal Hypoxic Ischemic Encephalopathy (HIE) on a point-of-care device

    Amount: $150,001.00

    DESCRIPTION provided by applicant Systemic asphyxia occurs in of births and can lead to hypoxic ischemic encephalopathy HIE Between and of neonates with HIE die or have permanent ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  2. Recombinant hepatic argininosuccinate synthase (rASS) for treatment of sepsis/end

    Amount: $580,950.00

    DESCRIPTION (provided by applicant): Multiorgan injury and failure due to septic complications result in significant morbidity and mortality, especially in pediatric and elderly patients with severe b ...

    SBIR Phase I 2011 Department of Health and Human Services
  3. Novel diagnostic and safety biomarkers of liver injury and hepatotoxicity

    Amount: $738,168.00

    DESCRIPTION (provided by applicant): Liver damage and failure due to various forms of hepatic injury is a significant source of overall morbidity and mortality in the US and worldwide. Persistent hepa ...

    SBIR Phase II 2008 Department of Health and Human Services
  4. Development of Novel Biomarkers for Traumatic Brain injury

    Amount: $526,091.00

    DESCRIPTION (provided by applicant): Each year in the United States at least 1.4 million people seek medical attention for a traumatic brain injury (TBI). Between 75% and 90% of these are mild or mode ...

    SBIR Phase II 2007 Department of Health and Human Services
  5. Biomarker for liver ischemia/reperfusion-induced injury

    Amount: $99,978.00

    DESCRIPTION (provided by applicant): Liver injury induced by hepatic ischemia followed by reperfusion is a major pathogenic cause of liver failure during multiple trauma, thermal injury, hemorrhagic a ...

    SBIR Phase I 2006 Department of Health and Human Services
  6. Novel Biomarkers for Stroke Injury

    Amount: $100,000.00

    Stroke is the second leading cause of death worldwide and the primary cause of serious, long-term disability and nursing home admissions. The absence of clinically useful diagnostics has severely impe ...

    SBIR Phase I 2005 Department of Health and Human Services
  7. High-Throughput Brain Injury Proteomic Microassay

    Amount: $99,685.00

    Traumatic brain injury (TBI) is a leading cause of combat casualty. Previous estimates for 20th century conflicts were that 15 - 25% of all injuries were sustained to the head. However, with the inc ...

    STTR Phase I 2005 Department of Defense Army
  8. Novel Biomarkers for Traumatic Brain Injury

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Injury is the leading cause of mortality among Americans under 45 years of age, and traumatic brain injury (TBI) is responsible for the majority of these deaths. T ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government